CV Sciences (CVSI) Total Non-Current Liabilities (2013 - 2026)

CV Sciences (CVSI) reported Total Non-Current Liabilities of $5.2 million for Q1 2026, down 10.99% on a YoY basis from $5.9 million in Q1 2025, and down 4.91% sequentially from $5.5 million in Q4 2025.

CV Sciences (CVSI) Total Non-Current Liabilities (2013 - 2026) Analysis & Trends

CV Sciences (CVSI) has 11 years of Total Non-Current Liabilities data on file, last reported at $5.2 million in Q1 2026.

  • For the quarter ending Q1 2026, Total Non-Current Liabilities fell 10.99% year-over-year to $5.2 million; the trailing twelve-month figure through Mar 2026 stood at $5.2 million (down 10.99% YoY), and the FY2025 full-year result was $5.5 million, down 10.4% from the prior year.
  • Total Non-Current Liabilities slipped to $5.2 million in Q1 2026, from $5.5 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $13.5 million in Q4 2022 to a low of $5.2 million in Q1 2026.
  • A 5-year average of $6.6 million and a median of $6.1 million in 2024 frame the typical range for Total Non-Current Liabilities.
  • Across the five-year window, Total Non-Current Liabilities sank 54.18% in 2023 and decreased 0.97% in 2024, its largest moves.
  • Tracing CVSI's Total Non-Current Liabilities over 5 years: stood at $13.5 million in 2022, then slumped by 54.18% to $6.2 million in 2023, then retreated by 0.97% to $6.1 million in 2024, then fell by 10.4% to $5.5 million in 2025, then decreased by 4.91% to $5.2 million in 2026.
  • Business Quant data shows CVSI's Total Non-Current Liabilities at $5.2 million in Q1 2026, $5.5 million in Q4 2025, and $5.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 14.92 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 18.28 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 11.64 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 33.47 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 599.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 20.09 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 1.24 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 6.26 Bn
10 CV Sciences 3.74 Mn 3.43 Mn 1.56 Mn 5.22 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 5.22 Mn
Dec 31, 2025 5.49 Mn
Sep 30, 2025 5.46 Mn
Jun 30, 2025 6.15 Mn
Mar 31, 2025 5.87 Mn
Dec 31, 2024 6.13 Mn
Sep 30, 2024 6.16 Mn
Jun 30, 2024 6.28 Mn
Mar 31, 2024 6.00 Mn
Dec 31, 2023 6.19 Mn
Dec 31, 2022 13.51 Mn
Dec 31, 2020 19.41 Mn
Sep 30, 2020 18.96 Mn
Jun 30, 2020 23.71 Mn
Mar 31, 2020 21.94 Mn
Dec 31, 2019 23.13 Mn
Sep 30, 2019 23.00 Mn
Jun 30, 2019 17.37 Mn
Mar 31, 2019 17.08 Mn
Dec 31, 2018 6.79 Mn